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Online Letters to the Editor

In conclusion, we appreciate the comments by Luglio et al
(1) and wish to reiterate that our study is one of only a few
pediatric studies of capnography measures in mechanically
ventilated children. We hope that as evidence accumulates,
more pediatric intensivists will join us and begin to monitor
and evaluate this important parameter.
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Hyperchloremia Versus Nonhyperchloremia
or Hyperchloremia Versus Normochloremia?
To the Editor:

I

n a recent issue of Critical Care Medicine, we read with
great interest the article by Neyra et al (1) presenting the
association of hyperchloremia with hospital mortality in
1,940 ICU adult patients with severe sepsis or septic shock.
The authors revealed that hyperchloremia (serum chloride
[Cl] ≥ 110 mEq/L) at ICU admission, higher Cl levels, and
within-subject worsening hyperchloremia at 72 hours of ICU
stay were associated with all-cause hospital mortality even after
adjusting base deficit, cumulative fluid balance, acute kidney
injury, and other critical illness parameters. These findings add
to the body of evidence showing harmfulness of hyperchloremia and seem to be attributable to the avoidance of chloriderich solutions in critically ill patients, as well as the studies of
Raghunathan et al (2) and Shaw et al (3).
We are curious of few things. First, authors divided
enrolled cohort into two groups; patients with hyperchloremia (Cl0 ≥ 110 mEq/L) and no hyperchloremia
(Cl0 < 110 mEq/L). The odds for outcomes were presented
comparing the hyperchloremic group with the nonhyperchloremic group. We wonder what would have happened
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if authors had divided enrolled cohort into two groups;
patients with hyperchloremia and normochloremia, excluding patients with hypochloremia. Serum chloride levels
would exert bimodal effect, such as pH, WBC, and so on.
Because hypochloremic patients were included in the nonhyperchloremic group in this study, statistical results would
be more impactive if authors excluded hypochloremic
patients. Also, the odds for outcomes comparing the hyperchloremic group with the normochloremic group may be
more acceptable to the physicians.
Second, the study by Tani et al (4) would be better not to
be mentioned in the discussion. Because Tani et al (4) tried to
determine the prognostic value of hypochloremia in critically
ill patients, it was out of focus to deal with hyperchloremia.
Then, studies that evaluated the association of hyperchloremia
with hospital mortality in critically ill patients showed consistent results as authors described (3, 5).
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potential conflicts of interest.
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The authors reply:

W

e reviewed Jo et al (1) correspondence in which they
have raised an important question regarding the
contribution of hypochloremia to our analysis (2).
In our original study (n = 1,940) (2), we stratified our primary
cohort by the presence (n = 615) or absence (n = 1,325) of
hyperchloremia (serum chloride ≥ 110 mEq/L) on ICU admission. Jo et al (1) suggested that the strength of the association
between higher serum chloride levels and hospital mortality in
the hyperchloremic group may perhaps be stronger if patients
with hypochloremia were excluded from the nonhyperchloremic group for comparison.
Consequently, we identified 361 patients with hypochloremia (serum chloride ≤ 100 mEq/L) on ICU admission in
www.ccmjournal.org

Copyright © 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

e53

Online Letters to the Editor

Table 1. Association of Hospital Mortality With Serum Chloride Levels at 72 Hours of ICU
Stay in a Secondary Cohort (n = 1,579) in Which Patients With Hypochloremia (Serum
Chloride ≤ 100 mEq/L) on Admission Were Excluded
Normochloremia at Admission
(Cl0 101–109 mEq/L)

Hyperchloremia at Admission
(Cl0 ≥ 110 mEq/L)
p

Odds Ratio

P

Odds Ratio

Cl72 per 5 mEq/L increase, univariate

1.05 (0.93–1.30)

0.26

1.38 (1.13–1.68)

0.002a

Cl72 per 5 mEq/L increase, multivariate

1.06 (0.87–1.30)

0.05

1.27 (1.02–1.59)

0.03a

Cl0 = serum chloride on ICU admission, Cl72 = serum chloride at 72 hr of ICU stay.
a
Statistically significant, p value < 0.05.
Multivariate models adjusted for age, gender, hypertension, acute kidney injury (Kidney Disease Improving Global Outcomes serum creatinine-based criteria),
oliguria, cumulative fluid balance, vasopressor or inotrope requirements, mechanical ventilation, Sequential Organ Failure Assessment score, and base deficit.
Multivariate models included all variables associated with hospital mortality on univariate analysis at p value < 0.10.

our primary cohort. To eliminate the effect of hypochloremia in our results, we performed a sensitivity analysis in a
secondary cohort that excluded patients with hypochloremia
on ICU admission. This secondary cohort consisted of 615
patients with hyperchloremia and 964 with normochloremia
(101–109 mEq/L) on ICU admission. We obtained similar
results and nearly identical univariate and multivariate logistic
regression estimates for the association of higher serum chloride levels with hospital mortality in the hyperchloremic group
as our published results (Table 1).
Small observational studies have demonstrated the association between hypochloremia and mortality in critically ill and
postoperative patients (3, 4). Jo et al (1) raised the question of
a possible bimodal effect of serum chloride levels on mortality
outcomes. However, in our primary cohort, there was no association between serum chloride levels at 72 hours and hospital
mortality in the hypochloremic group (n = 361): the univariate
odds ratio for each 5 mEq/L decrease in serum chloride was
0.96 (95% CI, 0.77–1.21).
The study by Tani et al (4) comprised interesting observations
of serum chloride levels and adverse hospital outcomes in critically ill patients. Importantly, in the multivariate model, serum
chloride was not independently associated with hospital mortality. However, the authors also reported the frequency of hospital
mortality in three subgroups (hypochloremia, normochloremia,
and hyperchloremia) and found the highest risk for mortality
in the hypochloremic group. The risk for hospital mortality was
not different between the normochloremic and hyperchloremic
groups: 14 of 364 (3.8%) versus three of 81 (3.7%). The lack of
difference between these two subgroups is statistically evident by
Fisher exact test (p = 1.00). We consider that this work constitutes a negative study for the association between hyperchloremia and hospital mortality as discussed in our article (2).
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Association of Postoperative
Hypoalbuminemia With Acute Kidney Injury
Following Liver Transplantation
To the Editor:

I

n a recent issue of Critical Care Medicine, we read with
interest the article by Sang et al (1) assessing association of hypoalbuminemia within two postoperative days
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